Pegfilgrastim vs. filgrastim in reducing risk of febrile neutropenia.

被引：0
|
作者：
Lyman, GH
Bernal, M
Badamgarav, E
Pinto, L
Dubois, RW
机构：
[1] Univ Rochester, Dept Med, Rochester, NY 14627 USA
[2] Zynx Hlth Inc, Beverly Hills, CA USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4393
引用
收藏
页码：170B / 171B
页数：2
相关论文
共 50 条
  • [31] Positive effect of education on the patients' understanding of febrile neutropenia.
    Dickerson, J
    Carson, S
    ONCOLOGY NURSING FORUM, 2006, 33 (02) : 396 - 396
  • [32] Compliance in guideline-based management of febrile neutropenia.
    Hoffman, Michael J.
    Yentz, Sarah
    Weaver, Charlotta
    O'Leary, Kevin
    Gandhi, Suchi
    Katzen, Jeremy
    Sutton, Sarah
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [33] Effectiveness of biosimilar filgrastim vs. original granulocyte colony-stimulating factors in febrile neutropenia prevention in breast cancer patients
    Isabel Puértolas
    Alberto Frutos Pérez-Surio
    María Aránzazu Alcácera
    Raquel Andrés
    María del Tránsito Salvador
    European Journal of Clinical Pharmacology, 2018, 74 : 315 - 321
  • [34] Cefepime monotherapy as initial treatment for patients with febrile neutropenia.
    Montalar, J
    Segura, A
    Bosch, C
    Galán, A
    Juan, O
    Yuste, A
    Molins, C
    ANNALS OF ONCOLOGY, 2000, 11 : 151 - 151
  • [35] Effectiveness of biosimilar filgrastim vs. original granulocyte colony-stimulating factors in febrile neutropenia prevention in breast cancer patients
    Puertolas, Isabel
    Frutos Perez-Surio, Alberto
    Aranzazu Alcacera, Maria
    Andres, Raquel
    del Transito Salvador, Maria
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (03) : 315 - 321
  • [36] Comparative effectiveness of pegfilgrastim biosimilars vs originator for prevention of febrile neutropenia: A retrospective cohort study
    Wang, Ching-Yu
    Vouri, Scott M.
    Park, Haesuk
    Heldermon, Coy
    Brown, Joshua
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2023, 29 (02): : 119 - 127
  • [37] Pegfilgrastim for primary prophylaxis of febrile neutropenia in multiple myeloma
    Claudio Cerchione
    Davide Nappi
    Giovanni Martinelli
    Supportive Care in Cancer, 2021, 29 : 6973 - 6980
  • [38] Pegfilgrastim for primary prophylaxis of febrile neutropenia in multiple myeloma
    Cerchione, Claudio
    Nappi, Davide
    Martinelli, Giovanni
    SUPPORTIVE CARE IN CANCER, 2021, 29 (11) : 6973 - 6980
  • [39] ORAL VS. INTRAVENOUS ANTIBIOTICS IN TREATMENT OF PAEDIATRIC FEBRILE NEUTROPENIA
    Vedi, Aditi
    Cohn, Richard J.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 145 - 145
  • [40] Overuse and underuse of pegfilgrastim for primary prophylaxis of febrile neutropenia
    Zullo, Andrew R.
    Lou, Uvette
    Cabral, Sarah E.
    Huynh, Justin
    Berard-Collins, Christine M.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (06) : 1357 - 1365
12345